SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Abgenix, Inc. (ABGX)
An SI Board Since December 1998
Posts SubjectMarks Bans
590 38 0
Emcee:  Henry Niman Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
340At the Needham presentation Withy had some words for partnered programs. Pfizer Icebrg-6/19/2004
339ABGX(IL/N) GS Conference update: ABX-EGF main focus Annual Earnings Expectationsmopgcw-6/14/2004
338But SunTrust downgrades. Can't find text. Cheers, Tucktuck-6/8/2004
337SSB Summary of Asco data: Amgen (AMGN)/Abgenix's (ABGX) ABX-EGF: Anothermopgcw-6/8/2004
336GS Take: ABGX (IL/N)/AMGN (OP/N): ASCO update on ABX-EGF in cancer. No Surprismopgcw-6/8/2004
335>>NEW ORLEANS--(BUSINESS WIRE)--June 6, 2004-- Amgen Inc. (Nasdaq:AMGN - Ntuck-6/7/2004
334>>NEW ORLEANS, June 5 (Reuters) - An experimental drug being developed by tuck-6/5/2004
333ssb on asco: Amgen (AMGN)/Abgenix (ABGX): Another EGF-R inhibitor of interest mopgcw-5/17/2004
332>>ABX-EGF in combination with paclitaxel and carboplatin for advanced non-tuck-5/4/2004
331SSB ABGX: Uneventful Quarterly Results; Upcoming ABX-EGF Presentations at ASCO mopgcw-4/29/2004
330GS: ABGX (IL/N): 1Q04 update, steady clinical progress 52-Week Range US$18-9 YTmopgcw-4/29/2004
329Abgenix "buy," target price raised Tuesday, April 27, 2004 12:37:01 PIcebrg-4/27/2004
328Tarceva effecttom pope-4/26/2004
327why the Gap Up today?Secret_Agent_Man-4/26/2004
326AACR posters... Sunday 8:00 AM - 12:00 PM 700 - Human antibody drug conjugates nigel bates-3/29/2004
325Panitumumab (ABX-EGF) [From today's AMGN PR. The mAb has at least three difIcebrg-3/23/2004
324GS CC replay info: Amgen Inc. EPS (FY Dec) 2004E $2.39, 2005E $2.84 Outperform/mopgcw-3/18/2004
323Abgenix to Hold Private Job Fair to Recruit for Large Number of Jobs in Manufactnigel bates-3/15/2004
322ADVISORY/Abgenix Scales Up! Monday March 15, 9:02 am ET Abgenix to Hold Private Icebrg-3/15/2004
3215:00PM Abgenix Earnings Correction (ABGX) 14.60 -0.23: -- Update -- Reuters ReseMike Learner-2/25/2004
320SSB: ABGX: Reports Q4 and FY03 Financials; Pipeline Update mopgcw-2/24/2004
319Abgenix Announces 2003 Fourth Quarter and Full Year Financial Results Businesmopgcw-2/24/2004
318Abgenix to Host Conference Call on Fourth Quarter and Full Year 2003 Financial Rbob zagorin-2/17/2004
317Raven Names Stephen Worsley Vice President, Business Development Thursday FebruaIcebrg-2/12/2004
316Also look at CEGE - they own shares of ABGX + have some interesting stuff.Valery Portnov-2/12/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News